SPIE Buys Swiss Life Sciences Firm nimeg ag to Grow Pharma Services
European engineering giant SPIE has acquired Swiss specialist nimeg ag, bolstering its footprint in pharmaceutical and biotech facility services.
If you follow the quietly booming world of industrial engineering services, here's a deal worth noting: SPIE, the European multi-technical services company that handles everything from energy infrastructure to communications, just snapped up nimeg ag — a Switzerland-based engineering firm focused squarely on the life sciences sector.
The acquisition, announced July 1, 2026, gives SPIE a stronger grip on a market that's been hard to ignore. Pharmaceutical and biotechnology facilities are increasingly complex, highly regulated environments that demand specialized engineering expertise — exactly what nimeg ag brings to the table. Think cleanrooms, process utilities, and the kind of precision infrastructure that keeps drug manufacturing running smoothly.
Read more Surventis Launches as Independent Automotive Coatings Leader →
For SPIE, this is about more than just adding a name to its portfolio. The company is explicitly looking to expand its industrial services footprint in Switzerland, a country that punches well above its weight in global pharma and biotech activity. Switzerland is home to some of the world's largest pharmaceutical companies, so planting a deeper flag there makes strategic sense.
The deal also reflects a broader trend in the engineering services space: large multi-technical firms are increasingly targeting niche, high-barrier sectors like life sciences where specialist know-how commands premium value and long-term client relationships. For SPIE, nimeg ag is a ready-made entry point into that world rather than building capability from scratch.
Continue reading at GlobalNewswire.
